148 related articles for article (PubMed ID: 17488881)
1. Low sensitivity of the positron emission tomography ligand [11C]diprenorphine to agonist opiates.
Hume SP; Lingford-Hughes AR; Nataf V; Hirani E; Ahmad R; Davies AN; Nutt DJ
J Pharmacol Exp Ther; 2007 Aug; 322(2):661-7. PubMed ID: 17488881
[TBL] [Abstract][Full Text] [Related]
2. Using [11C]diprenorphine to image opioid receptor occupancy by methadone in opioid addiction: clinical and preclinical studies.
Melichar JK; Hume SP; Williams TM; Daglish MR; Taylor LG; Ahmad R; Malizia AL; Brooks DJ; Myles JS; Lingford-Hughes A; Nutt DJ
J Pharmacol Exp Ther; 2005 Jan; 312(1):309-15. PubMed ID: 15347732
[TBL] [Abstract][Full Text] [Related]
3. Quantification of opioid receptor availability following spontaneous epileptic seizures: correction of [11C]diprenorphine PET data for the partial-volume effect.
McGinnity CJ; Shidahara M; Feldmann M; Keihaninejad S; Riaño Barros DA; Gousias IS; Duncan JS; Brooks DJ; Heckemann RA; Turkheimer FE; Hammers A; Koepp MJ
Neuroimage; 2013 Oct; 79():72-80. PubMed ID: 23597934
[TBL] [Abstract][Full Text] [Related]
4. Imaging endogenous opioid peptide release with [11C]carfentanil and [3H]diprenorphine: influence of agonist-induced internalization.
Quelch DR; Katsouri L; Nutt DJ; Parker CA; Tyacke RJ
J Cereb Blood Flow Metab; 2014 Oct; 34(10):1604-12. PubMed ID: 25005876
[TBL] [Abstract][Full Text] [Related]
5. Quantification of human opiate receptor concentration and affinity using high and low specific activity [11C]diprenorphine and positron emission tomography.
Sadzot B; Price JC; Mayberg HS; Douglass KH; Dannals RF; Lever JR; Ravert HT; Wilson AA; Wagner HN; Feldman MA
J Cereb Blood Flow Metab; 1991 Mar; 11(2):204-19. PubMed ID: 1847703
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of three structurally related ¹⁸F-labeled orvinols of different intrinsic activities: 6-O-[¹⁸F]fluoroethyl-diprenorphine ([¹⁸F]FDPN), 6-O-[¹⁸F]fluoroethyl-buprenorphine ([¹⁸F]FBPN), and 6-O-[¹⁸F]fluoroethyl-phenethyl-orvinol ([¹⁸F]FPEO).
Schoultz BW; Hjørnevik T; Reed BJ; Marton J; Coello CS; Willoch F; Henriksen G
J Med Chem; 2014 Jun; 57(12):5464-9. PubMed ID: 24933507
[TBL] [Abstract][Full Text] [Related]
7. Brain opioid receptor binding in early abstinence from alcohol dependence and relationship to craving: an [11C]diprenorphine PET study.
Williams TM; Davies SJ; Taylor LG; Daglish MR; Hammers A; Brooks DJ; Nutt DJ; Lingford-Hughes A
Eur Neuropsychopharmacol; 2009 Oct; 19(10):740-8. PubMed ID: 19595579
[TBL] [Abstract][Full Text] [Related]
8. Measurement of changes in opioid receptor binding in vivo during trigeminal neuralgic pain using [11C] diprenorphine and positron emission tomography.
Jones AK; Kitchen ND; Watabe H; Cunningham VJ; Jones T; Luthra SK; Thomas DG
J Cereb Blood Flow Metab; 1999 Jul; 19(7):803-8. PubMed ID: 10413036
[TBL] [Abstract][Full Text] [Related]
9. Opioid receptor imaging and displacement studies with [6-O-[11C] methyl]buprenorphine in baboon brain.
Galynker I; Schlyer DJ; Dewey SL; Fowler JS; Logan J; Gatley SJ; MacGregor RR; Ferrieri RA; Holland MJ; Brodie J; Simon E; Wolf AP
Nucl Med Biol; 1996 Apr; 23(3):325-31. PubMed ID: 8782244
[TBL] [Abstract][Full Text] [Related]
10. The automated radiosynthesis and purification of the opioid receptor antagonist, [6-O-methyl-11C]diprenorphine on the GE TRACERlab FXFE radiochemistry module.
Fairclough M; Prenant C; Brown G; McMahon A; Lowe J; Jones A
J Labelled Comp Radiopharm; 2014 May; 57(5):388-96. PubMed ID: 24692062
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the brain uptake of N-(cyclopropyl[11C]methyl)norbuprenorphine ([11C]buprenorphine) and N-(cyclopropyl[11C]methyl)nordiprenorphine ([11C]diprenorphine) in baboon using PET.
Shiue CY; Bai LQ; Teng RR; Arnett CD; Dewey SL; Wolf AP; McPherson DW; Fowler JS; Logan J; Holland MJ
Int J Rad Appl Instrum B; 1991; 18(3):281-8. PubMed ID: 2071440
[TBL] [Abstract][Full Text] [Related]
12. Comparison of [11C]diprenorphine and [11C]carfentanil binding to opiate receptors in humans by positron emission tomography.
Frost JJ; Mayberg HS; Sadzot B; Dannals RF; Lever JR; Ravert HT; Wilson AA; Wagner HN; Links JM
J Cereb Blood Flow Metab; 1990 Jul; 10(4):484-92. PubMed ID: 2161414
[TBL] [Abstract][Full Text] [Related]
13. Compartmental analysis of diprenorphine binding to opiate receptors in the rat in vivo and its comparison with equilibrium data in vitro.
Cunningham VJ; Hume SP; Price GR; Ahier RG; Cremer JE; Jones AK
J Cereb Blood Flow Metab; 1991 Jan; 11(1):1-9. PubMed ID: 1845764
[TBL] [Abstract][Full Text] [Related]
14. In vivo opiate receptor binding of oripavines to mu, delta and kappa sites in rat brain as determined by an ex vivo labeling method.
Richards ML; Sadée W
Eur J Pharmacol; 1985 Aug; 114(3):343-53. PubMed ID: 2998812
[TBL] [Abstract][Full Text] [Related]
15. Buprenorphine: differential interaction with opiate receptor subtypes in vivo.
Sadée W; Rosenbaum JS; Herz A
J Pharmacol Exp Ther; 1982 Oct; 223(1):157-62. PubMed ID: 6288917
[TBL] [Abstract][Full Text] [Related]
16. In vivo characterization of four types of opioid binding sites in rat brain.
Sadée W; Richards ML; Grevel J; Rosenbaum JS
Life Sci; 1983; 33 Suppl 1():187-9. PubMed ID: 6141486
[TBL] [Abstract][Full Text] [Related]
17. Brain opioid receptor binding in early abstinence from opioid dependence: positron emission tomography study.
Williams TM; Daglish MR; Lingford-Hughes A; Taylor LG; Hammers A; Brooks DJ; Grasby P; Myles JS; Nutt DJ
Br J Psychiatry; 2007 Jul; 191():63-9. PubMed ID: 17602127
[TBL] [Abstract][Full Text] [Related]
18. Quantitation of [11C]diprenorphine cerebral kinetics in man acquired by PET using presaturation, pulse-chase and tracer-only protocols.
Jones AK; Cunningham VJ; Ha-Kawa SK; Fujiwara T; Liyii Q; Luthra SK; Ashburner J; Osman S; Jones T
J Neurosci Methods; 1994 Mar; 51(2):123-34. PubMed ID: 8051944
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
